# Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

> **NCT01788384** · PHASE3 · COMPLETED · sponsor: **Watson Laboratories, Inc.** · enrollment: 708 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Clindamycin Phosphate / Benzoyl Peroxide Gel
- **DRUG:** Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%
- **DRUG:** Placebo (Vehicle Gel)

## Key facts

- **NCT ID:** NCT01788384
- **Lead sponsor:** Watson Laboratories, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 708 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01788384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01788384, "Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01788384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*